Beyond antigens and adjuvants: formulating future vaccines

Beyond antigens and adjuvants: formulating future vaccines

The need to optimize vaccine potency while minimizing toxicity in healthy recipients has motivated studies of the formulation of vaccines to control how, when, and where antigens and adjuvants encounter immune cells and other cells/tissues following administration. An effective subunit vaccine must...

Full description

Bibliographic Details
Main Authors: Moyer, Tyson (Contributor), Zmolek, Andrew Charles (Contributor), Irvine, Darrell J (Contributor)
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering (Contributor), Massachusetts Institute of Technology. Department of Chemical Engineering (Contributor), Massachusetts Institute of Technology. Department of Materials Science and Engineering (Contributor), Ragon Institute of MGH, MIT and Harvard (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor)
Format: Article
Language:English
Published: American Society for Clinical Investigation, 2017-04-18T20:03:05Z.
Subjects:
Article
Online Access:Get fulltext

Internet

Get fulltext

Similar Items